The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The family of 21-year NHL veteran Claude Lemieux is donating his brain to CTE research. The family announced in a statement that the four-time Stanley Cup champion's brain will be given to the UNITE ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Claude Lemieux’s brain is being donated to the Boston University CTE Center to research the long-term effects of repetitive brain injuries, his family said Saturday in a statement released by daughter ...

EDITOR’S NOTE: This story contains discussion of suicide. Claude Lemieux’s brain is being donated to the Boston University CTE Center to research the long-term effects of repetitive brain injuries, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

"No conclusions should be drawn at this time regarding any diagnosis," the family said in a statement. Claude Lemieux died this week at age 60. Michael Martin / NHLI via Getty Images Claude Lemieux’s ...

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...

1 Centre for Translational Neuroscience and Mental Health, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia 2 Department of Physical Medicine and ...